## Abstract ## BACKGROUND Invasive fungal infections, including candidemia, pose a major threat to patients with impaired immune defenses, including bone marrow transplantation (BMT) recipients. During 1992β1997, 845 women with multiple lymph node positive or metastatic breast carcinoma underwent
β¦ LIBER β¦
New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation
β Scribed by Elizabeth J. Shpall; Salomon M. Stemmer; Scott I. Bearman; Susan Myers; Malcolm Purdy; Roy B. Jones
- Publisher
- Springer US
- Year
- 1993
- Tongue
- English
- Weight
- 418 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Candidemia in women with breast carcinom
β
MagnΓΊs Gottfredsson; James J. Vredenburgh; Jianping Xu; Wiley A. Schell; John R.
π
Article
π
2003
π
John Wiley and Sons
π
English
β 224 KB
π 1 views
High-dose chemotherapy with autologous b
β
Takao Suzuki; Takenori Ochiai; Matsuo Nagata; Yoshio Koide; Yoshio Gunji; Kazuak
π
Article
π
1993
π
John Wiley and Sons
π
English
β 615 KB
High-dose combination chemotherapy with
High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors
β
Gary Spitzer; Karel A. Dicke; Joe Litam; D. S. Verma; Axel Zander; Victor Lanzot
π
Article
π
1980
π
John Wiley and Sons
π
English
β 931 KB
High-dose melphalan with 6-hydroxydopami
β
Brian H. Kushner; Jong-Hyo Kwon; Richard J. O'Reilly; Nai-Kong V. Cheung; Subhas
π
Article
π
1991
π
John Wiley and Sons
π
English
β 554 KB
Tandem high dose chemotherapy with autol
β
E. Randolph Broun; Craig R. Nichols; Gary Gize; Kenneth Cornetta; Robert A. Hrom
π
Article
π
1997
π
John Wiley and Sons
π
English
β 80 KB
π 2 views
The purpose of this study was to evaluate the use of two cycles of
Late intensification with high-dose melp
β
Mark D. Vincent; Trevor J. Powles; R. Charles Coombes; T. J. McElwain
π
Article
π
1988
π
Springer
π
English
β 557 KB
Fifteen patients with advanced breast cancer who had achieved either a good partial or a complete response to conventional chemotherapy were selected to receive intensification treatment with high-dose melphalan 140-200 mg/m2 (HDM). All patients received autologous bone marrow rescue. All patients e